Picture of Nu-Med Plus logo

NUMD Nu-Med Plus Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Nu-Med Plus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue00000
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses1.021.990.830.1320.121
Operating Profit-1.02-1.99-0.83-0.132-0.121
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-1.04-2.01-0.83-0.13-0.126
Provision for Income Taxes
Net Income After Taxes-1.04-2.01-0.83-0.13-0.126
Net Income Before Extraordinary Items
Net Income-1.04-2.01-0.83-0.13-0.126
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-1.04-2.01-0.83-0.13-0.126
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.023-0.037-0.011-0.002-0.002